From brand names like Mounjaro to Ozempic, these medications have been approved by the Food and Drug Administration to lower blood sugar levels
Starting on July 1, the temporary program is set to run for a year and a half through the end of 2027
doi: 10.1111/cob.12146 56
Collaborations are everywhere: We are seeing rapid strategic tie-ups, including ERIS Lifesciences with NATCO Pharma (India), OneSource Pharma with Hikma Pharmaceuticals (Saudi Arabia), and Ajanta Pharma Ltd with Biocon (Asia/Africa)
That price gap has fueled a parallel market of direct-to-consumer telehealth platforms and, more concerningly, unverified sellers a real risk given how injectable these drugs are and how much counterfeit-drug activity tends to follow any high-demand, high-price medication
Too much SHBG can lower free testosterone